Jake Nunn
InvestorPartner at SR One Capital Management · Board director at Trivascular
San Francisco Bay Area
Writes $50K – $50M checks · typically $25M
About
Jake Nunn is a Partner at SR One focusing on later-stage private and public biotech investments, with over 25 years in the life sciences industry as an investor, board director, research analyst, and investment banker. He was previously an investing partner at New Enterprise Associates (NEA) from 2006 to 2019, where he founded the firm's public healthcare investing practice, and earlier held roles at MPM Capital, Franklin Templeton Investments, and Alex. Brown & Sons. He holds an MBA from Stanford Graduate School of Business and a BA in Economics from Dartmouth College, and is a CFA charterholder.
Contact· self-published, not guessed
Invests in
Biotech
Board director at Trivascular
Intro paths
In turn, Jake can intro founders to Trivascular's investors below.
Trivascular's investors · 2
Co-founders at Trivascular
Experience
- SR One Capital ManagementPartnercurrent2024 — presentSan Francisco Bay Area
- SR One Capital ManagementVenture Partner2023 — 2024San Francisco Bay Area
- Zenas BioPharmaBoard Membercurrent2024 — presentWaltham, Massachusetts, United States
- Regulus TherapeuticsBoard Membercurrent2019 — presentSan Diego, California
- Addex TherapeuticsBoard Membercurrent2018 — presentGeneva, Switzerland
- Humanetics CorporationBoard Membercurrent2022 — presentMinneapolis, Minnesota, United States
- Trevena, Inc.Board Member2013 — 2024Chesterbrook, Pennsylvania
- Hexima Limited (ASX:HXL)Board Member2021 — 2023Melbourne, Victoria, Australia
- New Enterprise Associates (NEA)Venture Advisor2019 — 2022
- New Enterprise Associates (NEA)Partner2006 — 2018
- Oventus Medical LtdBoard Member2020 — 2022Brisbane, Queensland, Australia
- Qool TherapeuticsBoard Member2019 — 2021Mountain View, CA
- Dermira, Inc.Board Member2011 — 2020Menlo Park, California
- TriVascular, IncBoard Member2008 — 2016Santa Rosa, California
- Hyperion TherapeuticsBoard Member2009 — 2015South San Francisco, California
- Transcept Pharmaceuticals, Inc.Board Member2009 — 2014Richmond, California
- MPM CapitalPartner2001 — 2006
- Franklin Templeton InvestmentsPortfolio Manager1998 — 2000
- Alex. Brown & SonsAnalyst1994 — 1996San Francisco, California
- GEFinancial Analyst1992 — 1994San Jose, California
Skills & more
- Chartered Financial Analyst (CFA) — CFA Institute
From Jake's professional profile.
Deals · 4
Addex TherapeuticsBoard seat
via SR One Capital Management · filed Apr 2023 · $3.7M raise
Regulus Therapeutics Inc.Board seat
via SR One Capital Management · filed Dec 2021 · $34.6M raise
DermiraBoard seat
via SR One Capital Management · filed Dec 2018 · $1M raise
TrivascularBoard seat
via SR One Capital Management · filed Aug 2015 · $10M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Hyperion TherapeuticsRegulus TherapeuticsZenas BiopharmaZenas Biopharma
Sources: SEC Form D filings · the firm's website.
Colleagues at SR One Capital Management
Network3
Investors connected to Jake in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Jake Nunn?
- Jake Nunn is a Partner at SR One focusing on later-stage private and public biotech investments, with over 25 years in the life sciences industry as an investor, board director, research analyst, and investment banker. He was previously an investing partner at New Enterprise Associates (NEA) from 2006 to 2019, where he founded the firm's public healthcare investing practice, and earlier held roles at MPM Capital, Franklin Templeton Investments, and Alex. Brown & Sons. He holds an MBA from Stanford Graduate School of Business and a BA in Economics from Dartmouth College, and is a CFA charterholder.
- Where does Jake Nunn work?
- Jake Nunn is Partner at SR One Capital Management and Board director at Trivascular.
- What does Jake Nunn invest in?
- Jake Nunn invests in Biotech.
- What check size does Jake Nunn write?
- Jake Nunn typically writes checks of $50K – $50M.
- What boards does Jake Nunn sit on?
- Jake Nunn holds tracked board seats at Addex Therapeutics, Addex Therapeutics, Dermira, Dermira, Hyperion Therapeutics, Regulus Therapeutics, Regulus Therapeutics Inc., Trivascular, Zenas Biopharma, Zenas Biopharma.
- Where did Jake Nunn go to school?
- Jake Nunn studied at Stanford University Graduate School of Business (Master of Business Administration (MBA)); Dartmouth College (Bachelor of Arts (B.A.), Economics); Executive Education / Stanford Graduate School of Business (Directors' Consortium).
Same school
Also attended Stanford University Graduate School of Business1,385
+ 1,379 more
Also attended Dartmouth College409
+ 403 more
Shared employers
Also worked at SR One Capital Management29
+ 23 more
Also worked at Trevena, Inc.1
Also worked at New Enterprise Associates (NEA)118
+ 112 more
